Advances in radiotherapy and immunity in hepatocellular carcinoma

Advances in radiotherapy and immunity in hepatocellular carcinoma

Abstract Primary liver cancer is one of the most common malignant tumours worldwide; it caused approximately 830,000 deaths in 2020. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, accounting for over 80% of all cases. Various methods, including surgery, chemotherapy,...

Full description

Bibliographic Details
Main Authors: Yuhan Yang, Liting Xiong, Mengyuan Li, Ping Jiang, Junjie Wang, Chunxiao Li
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Journal of Translational Medicine
Subjects:
Hepatocellular carcinoma
Radiotherapy
Immunotherapy
Radioimmunotherapy
Online Access:https://doi.org/10.1186/s12967-023-04386-y

Similar Items

Similar Items